Literature DB >> 1689926

A control model for tibial cortex neovascularization in the bone chamber.

H Winet1, J Y Bao, R Moffat.   

Abstract

Neovascularization across a gap defect in a rabbit tibial cortex was monitored using the optical bone chamber implant (BCI). Cortical bone growing by apposition as trabeculae was observed weekly as it penetrated a slit into a tissue space in vivo and in situ. Each rabbit was viewed weekly with an intravital microscope from 3 to 8 weeks postimplantation. The constant field of view was the slit-gap tissue space, which was 100 microns thick and 2 mm in diameter. Vessels were imaged with epi-illuminated fluorescence microscopy as they carried FITC-dextran 70 that had been injected into an aural vein. Observations were videotaped and photographed. Videotape frames were analyzed with a digital image processing system to obtain measures of vessel length per unit volume (L/V) of fibroblastic granular tissue and trabeculae, caliber C, and flow velocity u, all as functions of time. Observations supported the conclusions that (1) neovascularization precedes neo-osteogenesis, (2) major vessels tend to align with the tibial axis, (3) bone apposition-generated destruction of fibrous granular tissue vessels stimulates fibrous granular tissue angiogenesis, which keeps its L/V constant, (4) L/V in trabeculae increases with time, and (5) blood supply (Q) and nutrient exchange in healing trabeculae are not positively correlated. Thus, O2 supply to the trabeculum cannot be predicted from Q alone because the nutrient exchange area is not constant. It was noted that an increase in the potential nutrient exchange area occurred in both fibrous granular tissue and osseous vessels and the volume fraction of blood decreased in the fibrous granular tissue and remained constant in the trabeculae.

Entities:  

Mesh:

Year:  1990        PMID: 1689926     DOI: 10.1002/jbmr.5650050106

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  7 in total

1.  Development of Injectable Citrate-Based Bioadhesive Bone Implants.

Authors:  Denghui Xie; Jinshan Guo; Mohammadreza Mehdizadeh; Richard T Tran; Ruisong Chen; Dawei Sun; Guoying Qian; Dadi Jin; Xiaochun Bai; Jian Yang
Journal:  J Mater Chem B       Date:  2015-01-21       Impact factor: 6.331

2.  In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds.

Authors:  Zarana S Patel; Hiroki Ueda; Masaya Yamamoto; Yasuhiko Tabata; Antonios G Mikos
Journal:  Pharm Res       Date:  2008-07-29       Impact factor: 4.200

Review 3.  [Pain management in non-juvenile, aseptic osteonecrosis].

Authors:  M Jäger; A Werner; S Lentrodt; U Mödder; R Krauspe
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

4.  Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model.

Authors:  Zarana S Patel; Simon Young; Yasuhiko Tabata; John A Jansen; Mark E K Wong; Antonios G Mikos
Journal:  Bone       Date:  2008-07-14       Impact factor: 4.398

5.  Neo-osteogenesis of haversian trabeculae through a bone chamber implanted in a rabbit tibial cortex: a control model.

Authors:  H Winet; J Y Bao; R Moffat
Journal:  Calcif Tissue Int       Date:  1990-07       Impact factor: 4.333

6.  Sustained release of sphingosine 1-phosphate for therapeutic arteriogenesis and bone tissue engineering.

Authors:  Lauren S Sefcik; Caren E Petrie Aronin; Kristen A Wieghaus; Edward A Botchwey
Journal:  Biomaterials       Date:  2008-04-11       Impact factor: 12.479

7.  Support Immersion Endoscopy in Post-Extraction Alveolar Bone Chambers: A New Window for Microscopic Bone Imaging In Vivo.

Authors:  Wilfried Engelke; Marcio Lazzarini; Walter Stühmer; Víctor Beltrán
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.